Home Cart 0 Sign in  

[ CAS No. 54029-12-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 54029-12-8
Chemical Structure| 54029-12-8
Structure of 54029-12-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 54029-12-8 ]

Related Doc. of [ 54029-12-8 ]

Alternatived Products of [ 54029-12-8 ]

Product Details of [ 54029-12-8 ]

CAS No. :54029-12-8 MDL No. :MFCD00797922
Formula : C12H15N3O3S Boiling Point : -
Linear Structure Formula :- InChI Key :VXTGHWHFYNYFFV-UHFFFAOYSA-N
M.W : 281.33 Pubchem ID :83969
Synonyms :
Ricobendazole;Albendazole Oxide;RS 8852
Chemical Name :Methyl (6-(propylsulfinyl)-1H-benzo[d]imidazol-2-yl)carbamate

Calculated chemistry of [ 54029-12-8 ]

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.33
Num. rotatable bonds : 6
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 73.9
TPSA : 103.29 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.99 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.38
Log Po/w (XLOGP3) : 1.45
Log Po/w (WLOGP) : 2.93
Log Po/w (MLOGP) : 1.13
Log Po/w (SILICOS-IT) : 1.05
Consensus Log Po/w : 1.59

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.45
Solubility : 0.993 mg/ml ; 0.00353 mol/l
Class : Soluble
Log S (Ali) : -3.22
Solubility : 0.168 mg/ml ; 0.000596 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.25
Solubility : 0.0158 mg/ml ; 0.0000561 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.01

Safety of [ 54029-12-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 54029-12-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 54029-12-8 ]
  • Downstream synthetic route of [ 54029-12-8 ]

[ 54029-12-8 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 34840-23-8 ]
  • [ 66868-66-4 ]
  • [ 54029-12-8 ]
YieldReaction ConditionsOperation in experiment
81% With acetic acid In methanol (6)
Preparation of [5-(Propylsulfinyl)-1H-benzimidazol-2-yl]carbamic acid, methyl ester
To 3.56 g (18 mMol) 4-(1-propylsulfinyl)-1,2-diaminobenzene in 45 ml methanol is added 1.03 ml acetic acid and 3.84 g (19.8 mMol) 1,3-bis(methoxycarbonyl)-S-methyl isothiourea.
The resulting solution is heated to reflux for 21/2 hours, cooled and the solvent stripped.
The white solid is digested with water, filtered, washed with ether and dried to yield 4.1 g of the title compound in the form of a white solid, m.p. 215°-216°, yield 81percent.
Reference: [1] Patent: US4076825, 1978, A,
  • 2
  • [ 54965-21-8 ]
  • [ 54029-12-8 ]
Reference: [1] Journal of Organic Chemistry, 1994, vol. 59, # 10, p. 2762 - 2765
[2] RSC Advances, 2014, vol. 4, # 87, p. 46545 - 46554
[3] ACS Medicinal Chemistry Letters, 2013, vol. 4, # 11, p. 1119 - 1123
[4] Xenobiotica, 1995, vol. 25, # 5, p. 433 - 441
[5] European Journal of Medicinal Chemistry, 2009, vol. 44, # 4, p. 1794 - 1800
[6] Drug Metabolism and Disposition, 2010, vol. 38, # 2, p. 347 - 356
  • 3
  • [ 54029-48-0 ]
  • [ 54029-12-8 ]
Reference: [1] Patent: US4076825, 1978, A,
  • 4
  • [ 54393-89-4 ]
  • [ 54029-12-8 ]
Reference: [1] Patent: US4076825, 1978, A,
Same Skeleton Products
Historical Records